Part 798 - Health Effects Testing Guidelines  


Subparts A--B - XXX
Subpart C - Subchronic Exposure
§ 798.2250 - Dermal toxicity.
§ 798.2450 - Inhalation toxicity.
§ 798.2650 - Oral toxicity.
Subpart D - Chronic Exposure
§ 798.3260 - Chronic toxicity.
§ 798.3300 - Oncogenicity.
§ 798.3320 - Combined chronic toxicity/oncogenicity.
Subpart E - Specific Organ/Tissue Toxicity
§ 798.4100 - Dermal sensitization.
§ 798.4350 - Inhalation developmental toxicity study.
§ 798.4700 - Reproduction and fertility effects.
§ 798.4900 - Developmental toxicity study.
Subpart F - Genetic Toxicity
§ 798.5195 - Mouse biochemical specific locus test.
§ 798.5200 - Mouse visible specific locus test.
§ 798.5265 - The salmonella typhimurium reverse mutation assay.
§ 798.5275 - Sex-linked recessive lethal test in drosophila melanogaster.
§ 798.5300 - Detection of gene mutations in somatic cells in culture.
§ 798.5375 - In vitro mammalian cytogenetics.
§ 798.5385 - In vivo mammalian bone marrow cytogenetics tests: Chromosomal analysis.
§ 798.5395 - In vivo mammalian bone marrow cytogenetics tests: Micronucleus assay.
§ 798.5450 - Rodent dominant lethal assay.
§ 798.5460 - Rodent heritable translocation assays.
§ 798.5500 - Differential growth inhibition of repair proficient and repair deficient bacteria: “Bacterial DNA damage or repair tests.”
§ 798.5955 - Heritable translocation test in drosophila melanogaster.
Subpart G - Neurotoxicity
§ 798.6050 - Functional observational battery.
§ 798.6200 - Motor activity.
§ 798.6400 - Neuropathology.
§ 798.6500 - Schedule-controlled operant behavior.
§ 798.6560 - Subchronic delayed neuro-toxicity of organophosphorus substances.